Summary
This website provides information about a once-daily oral PARP inhibitor used for the maintenance treatment of adults with advanced ovarian cancer. It offers details on the drug's efficacy, safety, dosing, and patient access programs. The site is targeted at healthcare professionals, providing resources for prescribing and patient management, including safety information and support services.
Based on content on zejulahcp.com
No similar companies found
We offer API access to our data.
7 of 8 checks passed
Label
Value
Active Dates
6.4 years — Since Aug 2018
Web Hosting
Platform
E-Mail Provider
NAICS Code
325412
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Pharmaceuticals and Oncology
2. Pharmaceutical Preparation Manufacturing
Vendor
Source
TXT Record
TXT Record
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
| 2024 |
|
|
|
|
|
|
|
|
|
|
|
|